Membrane Technology for Enzyme Separations - NBV
Membrane Technology for Enzyme Separations - NBV
Membrane Technology for Enzyme Separations - NBV
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
<strong>Membrane</strong> <strong>Technology</strong><br />
<strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
A case on efficient downstream processing<br />
in enzymatic routes to cefalosporins<br />
Emile van de Sandt and Marijn Rijkers
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
Contents<br />
• Introduction<br />
DSM<br />
– DSM<br />
– The process<br />
• The problem<br />
• First results<br />
• Process options<br />
• Process design<br />
• Project realization<br />
• Outlook
DSM: Company Profile 2009<br />
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
Life Sciences & Materials Sciences Company<br />
Global top 30 Chemical Industry<br />
DSM<br />
Net sales 2008: €9.3 billion<br />
Net profit 2008: €577 million<br />
23,591 employees<br />
of which in R&D: approx. 2,200<br />
of which in the Netherlands: approx. 7,200<br />
>200 locations on 5 continents<br />
No 1 or 2 in Dow Jones Sustainability Index<br />
in 2004 to 2008<br />
Strong technological toolbox:<br />
Integrated use of biotechnology, biocatalysis,<br />
organic chemistry, chemical and polymer<br />
technology, material sciences
DSM: Ability to change<br />
100 years of successful trans<strong>for</strong>mations<br />
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
Evolution<br />
DSM<br />
Coal<br />
Fertilizers<br />
Petrochemicals<br />
Life Science Products<br />
Per<strong>for</strong>mance Materials<br />
1902 1930 1950 1970 1990 2000 2010<br />
Classical Biotechnology<br />
Bioterials / Biologics<br />
sustainability<br />
Technological competences<br />
Mechanical engineering<br />
Chemical engineering<br />
Polymer technology<br />
Material science<br />
Fine chemicals<br />
Modern Biotechnology
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM Antibiotics Supply Chain<br />
DSM<br />
Glucose<br />
Side chain<br />
Glucose<br />
Side chain<br />
Glucose<br />
enzymatic<br />
conversions<br />
fermentation<br />
Raw materials<br />
Pen G 6-APA<br />
7-ADCA<br />
Intermediates<br />
Amoxicillin<br />
Ampicillin<br />
(di)Cloxacillin<br />
Flucloxallin<br />
Cephalexin<br />
Cefadroxil<br />
Cephradine<br />
Clavulanic acid<br />
Nystatine<br />
Enzyms<br />
Bulk-actives<br />
Penicillins<br />
Cephalosporins<br />
Other<br />
Formulation Retail
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
Innovation: Non-Natural Compound<br />
Metabolic Engineering, Biocatalysis, Bioprocessing<br />
DSM<br />
13 chemical steps<br />
replaced by: by<br />
1 fermentation +<br />
2 enzymatic steps<br />
65% less energy and<br />
50% lower cost<br />
Life Cycle Analysis<br />
Area use<br />
Resource<br />
consumption<br />
and materials<br />
Energy<br />
consumption<br />
1,00<br />
0,50<br />
0,00<br />
Risk<br />
potential<br />
Emissions<br />
Toxicity<br />
potential
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Cefalexin Green Alternative (CEGA)<br />
O<br />
H NH 2<br />
Enzymatic production process <strong>for</strong> Cefalexin<br />
Start-up Start up: : 1997 in Barcelona<br />
NH 2<br />
+<br />
H 2N<br />
O<br />
H H<br />
N<br />
S<br />
CO 2<br />
Pen-G-acylase<br />
H 2 O<br />
O<br />
H NH2<br />
Phenylglycine amide 7-ADCA ADCA Cefalexin<br />
H<br />
N<br />
O<br />
H H<br />
N<br />
S<br />
CO 2
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
Conversion<br />
(Immobilized<br />
enzyme)<br />
DSM<br />
Starting<br />
Materials<br />
Enzymatic Cefalexin Process Blockscheme<br />
Solution<br />
Product<br />
isolation Recovery<br />
Product Recycle<br />
materials<br />
Liquid<br />
Purge
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Specification<br />
R&D<br />
Design / Construction<br />
engineering<br />
contruction<br />
Start-up<br />
FDA-approval<br />
Pre-production<br />
Market Testing<br />
Project planning (beginning 1996)<br />
1996<br />
1997
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Description of problem<br />
Product out of specification.<br />
Dissolution test: Visual observation of turbidity<br />
Poor control of protein content in reactor effluent<br />
NOTE:<br />
TM<br />
Assemblase is still “in development”<br />
Fast and robust solution required<br />
Minimum interference with project targets and plans<br />
Characterize proteins: Mw = 10.000 to 100.000<br />
Develop technical solution: Choose Ultra Filtration
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
Conversion<br />
(Immobilized<br />
enzyme)<br />
DSM<br />
Starting<br />
Materials<br />
Enzymatic Cefalexin Process Blockscheme<br />
UF<br />
Unit<br />
Waste<br />
Concentrate<br />
Product<br />
isolation Recovery<br />
Product Recycle<br />
materials<br />
Liquid<br />
Purge
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Ultra Filtration<br />
Starting points<br />
Full batch operation, batch size 4000 liter<br />
Temperature 5°C<br />
Retain Molecules with Mw > 20.000<br />
Requirements<br />
Losses to sewage < 0,3 % of feed<br />
Effluent to recovery < 1,0 % of feed<br />
Extra residence time < 75 minutes<br />
Available washing liquid = 400 liter (minimize dilution)<br />
Time available <strong>for</strong> washing / cleaning: 90 minutes<br />
Water consumption <strong>for</strong> washing / cleaning < 1500 liter/batch<br />
Construction<br />
Sanitary design (no dead volumes, no cross-contamination, etc.)<br />
Installation space 8x9x2,5 m (skid preferred)<br />
Noise level: < 75 dB<br />
Control<br />
Normal operation is with local PLC control
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
First experiments<br />
1<br />
2<br />
3<br />
Feed: Effluent of reactor containing (immobilized) enzyme<br />
Equipment: Tubular membrane, area about 0,01 m 2 , cut-off 9 kD,<br />
PolyEtherSulphon membrane (PCI). Cross flow velocity: 0.25 m/s.<br />
Conditions: 3 bar, 5 °C. Concentration factor about 2.<br />
Repeat with same feed.<br />
Same equipment.<br />
Conditions: 6 bar, 5 °C. Concentration factor about 4.<br />
Repeat with feed containing (much) more proteins (worst case).<br />
Tubular membrane, area about 0,01 m 2 , cut-off 8 kD,<br />
PolySulphone membrane (PCI). Cross flow velocity: 0,25 m/s.<br />
Conditions: 6 bar, 5 °C. Concentration factor between 4 and 5.
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Results<br />
Product on spec. !<br />
Flux = const * Δ P<br />
High protein: fouling of membrane<br />
Low crossflow and<br />
fouling → lower flux<br />
20 liter/m 2 /h attainable (lab.)<br />
2. ES209, 6 bar, 5°C, CF=4<br />
1. ES209, 3 bar, 5°C, CF=2 3. PU608, 6 bar, 5°C, CF=4-5
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Process choices<br />
Batch versus continuous (“feed and bleed”): Choose Batch because of:<br />
Fit with (batch) process.<br />
Possibility <strong>for</strong> frequent cleaning (low risk).<br />
Constant flow versus constant pressure: Choose constant feed flow<br />
because of simpler design (no control valves).
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Process choices (continued)<br />
1 versus 2 hours operation time: Choose 1 hour operation time.<br />
Criterion<br />
Investment (area)<br />
Yield (hold-up)<br />
Installation space<br />
Cleaning fluid<br />
Energy consumption<br />
Flexibility<br />
1 hour<br />
+ Dfl 80000<br />
higher ?<br />
+ 6 m 2<br />
+ 50%<br />
+ 3 kW<br />
higher<br />
2 hours<br />
-<br />
-<br />
-<br />
-<br />
-<br />
-
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
<strong>Membrane</strong> types<br />
A. Tubular, typical “specific area”is 65 m2/m3<br />
Drainage is possible, washing is difficult<br />
B. Spiral wound, typical “specific area”is 2000 m2/m3<br />
Drainage and washing is possible<br />
Lab test: Filtration over a 20 kD membrane:<br />
Obtain a permeate from which final product was isolated<br />
with a protein content below detection limit.<br />
Per<strong>for</strong>mance in turbidity test was good.<br />
Product met specification.<br />
Pilot tests:<br />
Tubular and spiral wound membranes:<br />
On spec product obtained.<br />
No technical problems.
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Process choices (continued)<br />
Tubular versus spiral wound membranes: Not clear !<br />
Criterion<br />
Hold-up / conc. fact.<br />
Drainability<br />
Wash with small vol.<br />
Fouling<br />
Investment<br />
Variable cost<br />
Experience<br />
Tubular<br />
Much more !<br />
65 m 2 /m 3<br />
Good<br />
Difficult<br />
Lowest chance<br />
More expensive<br />
Little more<br />
Available within<br />
DSM<br />
Spiral wound<br />
Compact<br />
2000 m 2 /m 3<br />
Good<br />
Good<br />
Risk<br />
Less expensive<br />
-<br />
Not within DSM
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Pilot tests (part of 2 nd CEGA pre-production)<br />
PCI<br />
Tubular membranes, same type as in lab tests.<br />
Area 15,6 m 2 : Same scale as pre-production.<br />
Attained fluxes: About 20 liter/m 2 /h.<br />
Achieved concentration factor: 8-14 (not enough).<br />
Amafilter “alternative”<br />
Spiral wound membranes.<br />
Area 1,6 m 2 : Side stream. However: Suitable to process<br />
concentrate stream <strong>for</strong> PCI-unit (worst case).<br />
Attained fluxes: About 13 liter/m 2 /h.<br />
Achieved concentration factor: Up to 65 (enough).
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Result of pilot test (Amafilter)
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Options <strong>for</strong> full scale unit<br />
Always start with maximum membrane area.<br />
Reduce the area <strong>for</strong> maximum concentration factor.<br />
Max. time: 75’, Max. amount of washing water: 400 liter/batch.<br />
<strong>Membrane</strong> area’s according to quotations.<br />
Criterion<br />
<strong>Membrane</strong> area (m 2 )<br />
Washing water (liter)<br />
Required flux (l/m 2 /h)<br />
Loss to recovery (%)<br />
Loss to sewage (%)<br />
Tubular<br />
(13 stages)<br />
203<br />
200<br />
26<br />
2,1<br />
0,12<br />
Spiral<br />
(4 stages)<br />
230<br />
160<br />
17<br />
0,7<br />
0,22<br />
Spiral<br />
(3 stages)<br />
288<br />
200<br />
16<br />
0,6<br />
0,28<br />
Choose spiral wound membrane Ultra Filtration Unit
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Process design<br />
A. Size of housings: Choose standard size of 4”, 4 meters long<br />
B. Number of housings: 4<br />
C. Columns and pumps must be “drainable”: install on slope<br />
D. Pump requirements:<br />
= sufficient cross flow velocity<br />
= minimum heat input<br />
= different speeds (4 speeds + reverse (<strong>for</strong> water intake))<br />
= accurate (prefer positive displacement)<br />
= sanitary design<br />
Choose screw pumps type Mono<br />
E. Heat exchange:<br />
Requirements: Max. process temperature: 10 °C. Cool<br />
to 5°C in 15 minutes. Heating to 50 °C must be possible<br />
Secondary heating circuit (safety)<br />
Minimum volume (use booster pumps on utility side)<br />
Choose plate heat exchangers
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Design results<br />
Install four UF-units which can be operated individually<br />
Operations: Filling, filtration, draining, washing, rinsing, cleaning<br />
Prepare dedicated program to operate the UF-unit<br />
Number of washing steps<br />
To recovery (% from feed)<br />
Losses in purge (%)<br />
Calculated efficiencies<br />
Target 1 2 3<br />
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Construction<br />
Factory Acceptance Test (FAT)<br />
At workshop supplier<br />
Is the hardware installed (Installation Qualification, IQ)<br />
Does it work (with water) ? Test pumps, controls,<br />
alarms, valves (Operation Qualification, OQ)<br />
Site Acceptance Test (SAT)<br />
In plant<br />
Does the integrated unit meet the targets ?<br />
Waterbatches + number of production batches<br />
= Process guarantees (yield + capacity)<br />
= Pressure tests<br />
= Alarms<br />
= Noise<br />
= Protocols, training
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Specification<br />
R&D<br />
Design / Construction<br />
engineering<br />
contruction<br />
Start-up<br />
FDA-approval<br />
Pre-production<br />
Market Testing<br />
Project realisation (1997)<br />
1996<br />
1997
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Contributors....<br />
DAI R&D team (Geleen / Spain) (Will v.d. Tweel, Eric Roos c.s.)<br />
<strong>Membrane</strong> specialists (Veerle Cauwenberg, Paul Vergossen)<br />
Amafilter (Manufacturer; Jan Gosker, André Wortel, Klaas Doedens)<br />
DAI Chemferm maintenance (Antoni Serra c.s.)<br />
DAI Production (Jordi Savall c.s.)<br />
CEGA project (& start-up) team (Kees v. Helden c.s.)<br />
MdE (Detailed engineering; M. de Morales c.s.)<br />
DAI services (Purchasing, engineering, acceptance tests...;<br />
Ben Voorn, Frits Leemker, Jerry Esmeijer, Ben Jansen + others)
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
AreaPlant<br />
=<br />
Area<br />
DSM<br />
Lab<br />
Volume<br />
Volume<br />
Plant<br />
Lab<br />
Area<br />
Investment a0<br />
a1<br />
* + =<br />
Relevant scale-up <strong>for</strong>mula’s<br />
=<br />
Volume<br />
Flux * Time<br />
α<br />
β<br />
* f ( imp.<br />
time)<br />
* f ( process)<br />
* f ( manuf<br />
Area<br />
Investment<br />
Area<br />
.)<br />
Variable cost<br />
γ
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Good options:<br />
Further scale-up<br />
Install fifth unit (up to 25% more capacity)<br />
Increase pressure and optimize circulation.<br />
Install membranes with higher cut-off.
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Good options:<br />
Further scale-up<br />
Install fifth unit (up to 25% more capacity)<br />
Increase pressure and optimize circulation.<br />
Install membranes with higher cut-off.<br />
Better option:<br />
Make process continuous.
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Good options:<br />
Further scale-up<br />
Install fifth unit (up to 25% more capacity)<br />
Increase pressure and optimize circulation.<br />
Install membranes with higher cut-off.<br />
Better option:<br />
Make process continuous.<br />
Best option:<br />
No protein release anymore (skip UF)
<strong>Membrane</strong> <strong>Technology</strong> <strong>for</strong> <strong>Enzyme</strong> <strong>Separations</strong><br />
DSM<br />
Thank you !